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Summary The primary aims of this study were purification and molecular cloning of a putative retrovirus
designated human mammary tumour virus (HMTV). However, our preliminary unpublished data of negative
reverse transcriptase (RT) activity in ostensibly 'infected' cells led us to re-examine the evidence for this virus;
namely multinucleate giant cell (MNGC) formation and RT activity in cultured blood monocytes from breast
cancer patients versus benign breast tumour and normal control subjects. MNGCs form by fusion of
monocytes and we estimated the total number of cell fusions which had occurred after 10 days of culture in
vitro by counting cells with two, three, four and five or more nuclei (n) and by measuring the density of
adherent mononuclear cells for each subject studied. We found no clear-cut difference in MNGC formation
between the three subject groups. Moreover, a substantial number of cultures, encompassing the three groups,
showed far more MNGCs per 105 monocytes than previously reported. Various parametric and non-
parametric statistical analyses were performed on the multinucleate cell data and only one parametric test,
which utilised the density of monolayers as a co-variate, showed a statistically significant difference at the 5%
level between the breast cancer and the normal subject groups. We observed marked subject-to-subject
variation in multinucleate cell formation and we suggest that the evidence for a difference between the breast
cancer and the normal groups is marginal. Further, MNGC formation by breast cancer monocytes may not be
attributed to the presence of a retrovirus since 5'-Azacytidine (AZA), an agent known to stimulate replication
of latent retroviruses showed no effect on the MNGC formation. In addition, culture supernatants from the
three groups were assayed for RT activity and no test sample gave a significant signal above background.
Preliminary transmission electron microscopy analysis failed to identify viral particles in MNGCs.
Breast cancer is the commonest cancer in women and in the
35-55 age range it is the principal cause of death amongst
women (Baum, 1988). It is currently estimated that in 12
women will develop the disease. Furthermore in the Western
hemisphere the annual incidence and mortality rates appear
to be on the increase (Baum, 1988).
It has become clear that the clinical onset of breast cancer
is influenced by several factors. Amongst these are: (i) the
number of menstrual cycles occurring prior to the first full-
term pregnancy, (ii) a genetically based predisposition for
this disease which is tempered by environmental and cultural
factors (Baum, 1988), and (iii) the frequency of spontaneous
mutation arising following exposure to ionising radiation
(Baum, 1988) and oncogenic transformation (Slamon et al.,
1987; Slamon et al., 1989).
One other factor which has represented a major focus of
investigation is the potential involvement of a virus of the
family Retroviridae in the aetiology of breast cancer. This
stems from studies in murine model systems in which a
retrovirus designated murine mammary tumour virus
(MMTV) has unequivocally been demonstrated to cause
breast cancer (see Peters & Dickson, 1987 for review). The
virus has been isolated, its entire genome sequenced and
much information has been obtained concerning mechanisms
by which proviral DNA becomes integrated into the murine
genome and the regulation of virus expression (Peters &
Dickson, 1987; Dickson, 1987; Peters et al., 1989). The
existence of a human mammary tumour virus (HMTV) has
been proposed and disputed for many years (McGrath et al.,
1974; Al-Sumidaie et al., 1988; Kirk & Gardiner, 1988; Prit-
chard & Mitchell, 1988; Baum et al., 1988). The positive
evidence for this has followed from two lines of investigation.
The first involved isolation and characterisation of retrovirus
like particles present in the culture fluid of cell lines derived
from the pleural effusion of breast cancer patients (McGrath
et al., 1974; Keydar et al., 1984; Keydar et al., 1989). A
second line of evidence was based on observations of in vitro
cultured peripheral blood monocytes. Six and 9 day cultures
of monocytes from breast cancer patients contained signifi-
cant numbers of multinucleate giant cells (MNGCs) in com-
parison with either an absence of, or low numbers in, control
cultures (Al-Sumidaie, 1986; Al-Sumidaie et al., 1986).
Though notable, these data were not compelling as MNGCs
were known to form in tissues due to the presence of a wide
variety of infectious agents or the presence of inorganic or
organic irritants (Postlethwaite et al., 1982; Poste, 1972;
Chambers & Spector, 1982).
Our interest in this area was stimulated by the report
(Al-Sumidaie et al., 1988) of significant levels of reverse
transcriptase (RT) activity in culture supernatants of mono-
cytes from breast cancer patients. This RT activity was
associated with particles having a buoyant density similar to
that of other retroviruses and was absent from the majority
of control cultures. The primary aim of this study was the
isolation and molecular cloning of HMTV. However, follow-
ing our preliminary observations of negative RT activity in
cells putatively 'infected' with HMTV, our revised aim was to
re-evaluate MNGC formation and RT activity in cultured
peripheral blood monocytes from breast cancer, benign
breast tumour and normal control subject groups. Our study
includes a more comprehensive statistical analysis of multi-
nucleate cell data than that previously described (Al-Sumi-
daie, 1986; Al-Sumidaie et al., 1986). We report an absence
of RT activity and the lack of any clear-cut difference in
MNGC formation between the three subject groups.
Materials and methods
Subjects
The study included 24 female subjects with breast carcinoma
(subject cancer, SC), 14 female subjects with current or
previous benign breast disease (subject benign, SB) and 24
healthy female volunteer subjects (subject normal, SN) with
no evidence of breast disease. Members of the SC and SB
groups were of age 27-75 years with 36 subjects being 36
years of age or older. Members of the SN group were of age
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34-70 years. Diagnosis of breast cancer or benign breast
disease was based on clinical and radiological findings to-
gether with a histological examination of the excised tumour.
Collection ofblood
Thirty millilitres of peripheral venous blood was collected
from subjects into three glass vacutaner tubes each contain-
ing lO'IU ml-' preservative free heparin. Blood was collected
from breast cancer patients prior to surgery and induction of
chemotherapy. All blood samples were processed within 2 h
of collection, for either MNGC or RT analysis as this
volume of blood yielded numbers of mononuclear cells ade-
quate for only one of the two studies.
Cultivation ofadherent blood mononuclear cells
Mononuclear leucocytes were separated from heparinised
blood following its three fold dilution in phosphate buffered
(0.01 M) saline (0.15 M) pH 7.2 and centrifugation (800 g,
15 min) over a sodium metrizoate (9.6% w/v)/ficoll (5.6%
w/v) gradient (Lymphoprep, Nycomed, Torshov, Norway)
according to the procedure of Boyum (1964). Mononuclear
cells were washed once by centrifugation (400 g, Omin) in
tissue culture medium (TCM) composed of Dulbecco's
modified Eagles Medium (DMEM, Flow, Rickmansworth,
Herts, UK) supplemented with L-glutamine (4 mM),
NaHCO3 (3.7 g 1-), pencillin (40,000 IUml-1) and strep-
tomycin (20,000 IU ml-l). Counts of viable cells were deter-
mined by trypan blue exclusion (Tullis, 1953) and cells were
adjusted to the appropriate concentration in complete tissue
culture medium (CTCM, TCM containing 10% v/v heat
inactivated pooled female human AB serum). Cells were
plated into Labtek tissue culture slides (Miles Laboratories,
Glamorgan, CF31 3TY, UK) as follows: for MNGC analysis
cells were brought to 5 x 106 ml-' and 450 LLl dispensed per
chamber of an eight chambered tissue culture slide. Two to
three chambers were utilised for each time-point studied
(days 4 and 10); for RT analysis cells were brought to
7 x 106ml' and 3.5 ml dispensed into each of two one-
chambered tissue culture slides. Incubation was at 37°C in an
atmosphere of air:C02 (95:5). After 2 h non-adherent cells
were removed by gentle aspiration and the adherent cells
washed with warm CTCM thus leaving an enriched
monocyte culture. Following a further 12-16 h incubation
this washing process was repeated and the medium replaced
with appropriate volumes of either CTCM or CTCM supple-
mented with 15 ILM-' 5' azacytidine (CTCM + AZA) as
required (see Figure 1). AZA is known to stimulate the
activity of latent retroviruses (Al-Sumidaie et al., 1988). After
7 days of in vitro culture the medium was gently aspirated
from MNGC cultures and replaced using prewarmed CTCM
or CTCM + AZA as indicated in scheme a of Figure 1.
Cultures were fixed following a total of either 4 or 10 days
incubation by gentle aspiration of the culture medium which
was replaced with prewarmed gluteraldehyde fixative (2% v/v
in 0.1 M cacodylate buffer). The adherent cell preparations
were stained using May-Grunwald and Giemsa stains (BDH
Ltd., Dagenham, Essex, UK) at least 2 h after fixation and
then mounted using glass coverslips and DEPEX (BDH).
These slides were then used for differential cell counts des-
cribed below.
For RT analysis adherent mononuclear cells were cultured
for 21 days. After 7, 10, 14 and 17 days in vitro the culture
medium was gently aspirated and replaced with fresh pre-
warmed CTCM + AZA. Culture supernatants collected at
days 7, 10, 14, 17 and 21 were clarified for removal of
cellular debris by centrifugation (1250g, 10mins) and were
stored at - 70°C prior to RT assay. Figure 1, scheme b
illustrates the protocol for maintenance of RT cultures.
Cell counting and analysis
Differential counts of the numbers of cell with 2, 3, 4 and 5
or more nuclei in 12 microscope fields (x 200) were per-
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Figure 1 Schematic protocol for initiation and maintenance of in
vitro cultured peripheral blood mononuclear cells for MNGC and
RT analysis.
formed on day 10 cultures. We observed that the percentage
of adherent cells and thus the monolayer density of day 10
cultures varied between subjects. Multinucleate cells form by fusion of monocytes (Postlethwaite et al., 1982) and the
frequency offusion must be related to the monolayer density.
Monocyte density counts were carried out automatically
using a SEM-IPS computerised system (Kontron Electrons
Ltd, Watford, UK) interfaced to a Zeiss Axiophot photo-
microscope (Carl Zeiss (Oberkochen) Ltd., Welwyn Garden
City, Herts, AL7 ILU) via a 3CCD colour video camera.
Day 10 cultures were not suitable for automated density
analysis as by this time very flat and elongated cells pre-
dominated and consequently the boundary between individ-
ual cells was not always clear. This was particularly the case
when large numbers of MNGCs were present. Therefore
monocyte density analysis was carried out using the same
preparation of each subjects cells following 4 days of in vitro
culture. This involved an automated count of all monocytes
present in 12 fields (x 200). The cell analyser was program-
med to exclude lymphocytes from cell density counts on the
basis of their smaller size and characteristics of nuclear
chromatin staining. The 12 microscopic fields for the
differential multinucleate cell counts and monocyte density
counts were selected such that the same central area of the
culture chambers were scored for each subject. The slides
were coded and read blind, i.e. without reference to the
subject from which the cells had been cultured. The code was
necessarily broken after all raw data was collected and prior
to the statistical analyses.
Determination ofreverse transcriptase activity
Crude viral pellets were generated by centrifugation
(100,000 g, 2 h, 4°C) of pooled culture supernatants which
were collected following 7, 10, 14, 17 and 21 days of culture.
The crude pellets were taken up in 100 Jll of TE (10 mM Tris
pH 8.0, 1 mM EDTA) and duplicate 10 1l samples were
assayed directly for RT. In later experiments the crude viral
pellets were taken up in 500ytl of TE and layered on top of a
sucrose step gradient composed of 60% w/v (2 ml), 30% w/v
(1 ml) and 15% w/v (1.5 ml). Gradients were centrifuged
(85,000g) for 16 h at 4°C. The putative virus was harvested
as 2 x 250 ftl fractions taken above and below the 30%/60%
sucrose interface. The fractions were pooled, diluted and a
concentrated viral pellet was generated by centrifugation
(150,000g) for 1 h at 4°C. The supernatant was carefully
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removed and the concentrated viral pellet taken up in TE to
approximately 50ftl. RT assays were performed on these
preparations.
Assayfor reverse transcriptase
Following optimisation experiments, reverse transcriptase
activity was routinely detected by the incorporation of radio-
labelled thymidine or deoxyguanosine triphosphate (TTP or
dGTP) into DNA in the presence of a synthetic homo-
polymer RNA template. Reaction buffer conditions were as
follows: 50 mM Tris-HCl, pH 8.3; 50 mM KCI; 8 mM MgCl2;
10 mM DTT; 0.1% NP40; 50pM TTP or dGTP; poly A/dT or
poly C/dG at 5fig ml-'; and 1011Ci 32P-TTP or 32P-GTP in a
final reaction volume of 100ftl. The test sample constituted
50,ul of the final volume. Incubation was for 60 min at 37°C
and the reaction was stopped by boiling (30 s). Radio-
labelled nucleic acid material was collected by either binding
to DE81 discs (Maniatis et al., 1982) or by precipitation
using 10% w/v trichloracetic acid. Radioactive incorporation
was determined by scintillation counting using a Beckman LS
counter Model 1801 (Beckman Instruments, Inc. Palo Alto,
CA 94304, USA).
Mouse mammary tumour virus
This virus provided a positive control for monitoring yield of
virus following the above purification steps and for RT
activity in assays. A concentrated preparation of MMTV was
kindly provided by Dr Clive Dickson, Imperial Cancer Re-
search Fund, Lincoln's Inn Fields, London WC2A 3PX. It
was prepared by collective centrifugation (90,000g, 4°C) of
approximately 1200 ml of supernatant from MMTV infected
GR cells (Ringold et al., 1975). The crude viral pellet of
MMTV was taken up in 1 ml of TE and was stored as 20yl
aliquots at - 70°C. RT assays utilised 10iLl of a 1/100 dilu-
tion of this preparation.
Electron microscopy
Samples of cultured cells were fixed in 2% glutaraldehyde in
0.1 M cacodylate buffer pH 7.2, were processed for transmis-
sion electron microscopy (TEM). Following fixation in glut-
araldehyde and buffered 1% osmium tetroxide the cells were
washed in cacodylate buffer, dehydrated in acetone and
embedded in Spurr epoxy resin in one of two ways. The cells
were either scraped off the slides to form a pellet or left as a
monolayer and processed in situ. Semi-thin (1 tim) sections
were cut, stained with methylene blue-azure 11-basic fuchsin
and examined by light microscopy. Areas of MNGCs were
selected in the blocks and thin sections (70-90 nm) were cut,
collected on copper/palladium G200 grids, stained with
aqueous uranyl acetate and lead citrate (LKB, 2168, Ultro-
stainer, Cambridge Instruments Ltd., Bar Hill, Cambridge,
UK) and examined at an accelerating voltage of 80 KV in a
Philips 301 transmission electron microscope.
Results
Morphological observations ofcultured cells
Day 10 cultures of the majority of subjects showed cells with
two, three, four and > five nuclei (n) with 2 n and 3 n cells
representing a substantial proportion of the multinucleate cell
population. Cells typical of those observed at day 10 are
shown in Figure 2. Cells with five or more nuclei (> 5 n)
were grouped together when performing differential cell
counts, however some subjects showed giant cells with 20-35
nuclei. The three types of MNGCs: foreign body, Langhans
and Touton (Chambers & Spector, 1982), were observed in
our day 10 cultures with the first two types being seen more
frequently than the latter.
In contrast to the deep purple staining of chromatin in
monocytes and lymphocytes, MNGCs characteristically
showed pale blue staining of their nuclei which invariably
contained one to three deep purple nucleoli. Preliminary data
(not shown) of cell analysis on day 10 adherent monocyte
cultures following silver staining for nucleolar organising
regions (NORs) suggest that MNGCs generally contain more
(three to five) NORs in comparison with mononucleate cells
(one to two NORs, data not shown). Together these mor-
phological observations suggest that the nuclei of MNGCs
are active containing DNA which is not supercoiled and in
tight association with histone and non-histone proteins.
Quantitative analyses
Differential count data from day 10 cultures in CTCM were
available from 22 normal, eight benign and 16 cancerous
subjects. Of these, 13 normal (SN), five benign (SB) and
seven cancerous (SC) also provided day 10 samples in
medium supplemented with AZA. There was one additional
day 10 SB culture grown in AZA. Usually, there was a day
four density reading corresponding to each day 10 culture.
However, for two subjects (one SB and one SC with day 10
data in both media), there were no density data available.
For six further subjects, there were density readings in only
one of the two media for which day 10 data were available.
In the following analyses, all the data that are relevant to
each question were included. In particular, when adjusting
for cell density, a day 4 reading in one medium was used
with a day 10 reading in the other if the alternative was to
discard data.
The analysis asked three questions:
1. Was there a difference in the rate of formation of
MNGCs between the SC, SB and SN groups?
2. Was there a difference in the effect of AZA on the
rate of MNGC formation between groups?
3. Was there a difference in the size distribution of mul-
tinucleate cells between groups?
The rate offormation of giant cells was examined prin-
cipally by looking at the total number of cell fusion events.
This was calculated for each preparation by multiplying the
number of cells in a category (two, three, four and five or
more nuclei) by the number of fusions that must have occur-
red to form a cell of that type (in all cases one less than the
number of nuclei) and summing these numbers.
i.e. Total fusions = ('2n') + (2x'3n') + (3x'4n') + (4x' > Sn')
where 'Xn' is the number of cells counted with X nuclei
per unit area (= 12 microscopic fields, x 200).
This statistic was biased to some extent because cells with
five or more nuclei were all placed in the same category for
practical reasons. It could also be argued that only the
'larger' of the multinucleate cells were evidence of the pre-
sence of a retrovirus. Therefore the number of 'large' cells
(defined as cells with four or more nuclei) observed for each
subject was also analysed as in previously reported analyses
of similar data (Al-Sumidaie, 1986; Al-Sumidaie et al., 1986).
Both total fusions and number of large cells were analysed
(using analysis of variance) on a log scale because the data
showed a skewed distribution. Before log-transforming, a
small constant (five for fusions and one for large cells) was
added to all the observations. The particular values chosen
are somewhat arbitrary, but serve to reduce the influence of
values close to zero that are disproportionately affected by
observational variation.
We observed that the density of glass-adherent cells (which
must affect the frequency of cell fusion) varied between sub-
jects, but was not readily estimated from day 10 cultures.
Therefore, a subsidiary question was whether the analyses
could be improved by adjusting for cell density using the
values obtained from the day 4 cultures as a co-variate.
Firstly it was necessary to look for differences between the
groups in their day 4 density readings, as these would affect
the interpretation of any other analyses. Analysis of variance
(on a log scale and performed separately for normal and
AZA media) revealed no evidence of such differences (data
not shown).THE PUTATIVE HUMAN MAMMARY TUMOUR RETROVIRUS 537
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Figure 2 Glass adherent mononuclear and multinucleate cells with two, three, four and > five nuclei typically seen in day 10
cultures (Magn x 200). Cells with two and three nuclei (arrowed) form a significant component of the multinucleate cell
population. a, b, and d. Some cultures contained very large cells with up to 35 nuclei present c.
Data revealed a clear association between monolayer den-
sity and formation of multinucleate cells (Figure 3). The
overall trend was that high monolayer density was associated
with large values for total cell fusions and numbers of large
cells. This relationship formed a basis for the co-variate
analysis performed on total cell fusions and numbers of large
cells present in day 10 cultures and the results are shown in
Table I. There was an observed trend of increasing values
from the normal group through the benign to the cancerous
group for both total cell fusions and numbers of large cells
(Table I). A direct t-test between the SC and SN groups was
statistically significant at the 5% level for both analyses, but
F-tests were not. Given the large subject to subject variation
it might be argued that a larger sample is needed. Never-
theless, the present study does not support the existence of a
substantial and clear-cut difference between normal subjects
and subjects with malignant disease as reported by others
(Al-Sumidaie, 1986; Al-Sumidaie et al., 1986).
Because of some uncertainty surrounding the distribution
of the data, equivalent non-parametric tests to the above
were performed, but without attempting to adjust for density.
These were the Kruskal-Wallis analysis of variance for
overall differences between the groups, with Mann-Whitney
U-tests for differences between particular pairs. None of
these analyses produced a statistically significant result. In
addition it was noted that five out of the 16 cancer subjects
had cultures containing very large cells with 10 to 35 nuclei.
This was higher than the corresponding proportion of the
normal subjects (three out of 22), but not significantly
different by Fisher's exact test.
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Figure 3 A plot of In adherent monocyte density vs In total cell
fusions which had occurred following in vitro cultivation in
CTCM for the three subject groups: * SN; 0 SC; and A SB. A
similar plot was obtained for large cell data.
The effect of 5'-azacytidine (AZA) on multinucleate cell
formation was evaluated using only those subjects for which
there was differential cell count data available for both
CTCM and CTCM + AZA treatments. The aim of the
analysis was to establish whether AZA treatment increased
MNGC formation, presumably by promoting viral growth.
Further we aimed to determine whether such an effect was
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Table I Analysis ofmultinucleate cell formationa
Total cellfusions SN SB SC
Mean: log scale 2.152 2.373 2.471
s.e: log scale 0.090 0.160 0.121
Mean: natural scale 137 231 291
n:b 22 7 15
Numbers oflarge cellsc SN SB SC
Mean: log scale 1.145 1.264 1.538
s.e.: log scale 0.123 0.217 0.149
Mean: natural scale 13 17 34
n:b 22 7 15
aThe analysis was based on differential counts ofcells cultured for 10
days in CTCM with adjustment forcell density; bn -numberofsubjects
in group; cLarge cells have four or more nuclei.
significant in only the cancerous group as this would be
consistent with a virus being present in SC cells and absent
from SB and SN cells. Both the fusion and large cell data
were analysed and the results are shown in Table II. These
analyses were not adjusted for density: the comparisons of
interest are made within subjects and hence 'automatically'
adjusted for density and other between-subject differences. It
is clear that there is no evidence of an effect of AZA treat-
ment either overall or differentially between the groups.
The size distribution of multinucleate cells between the
groups was examined by calculation of the number of cells in
each category (two, three, four and five or more nuclei) as a
percentage of the total number of multinucleate cells ob-
served for a subject. Analyses of variance for the percent of
cells in each category were performed separately for the
CTCM and CTCM + AZA treatments. There was no evi-
dence of a difference in the size distribution of multinucleate
cells between the SC, SB and SN groups (data not shown).
Assayfor reverse transcriptase activity
Supernatants collected from mononuclear cell cultures of a
total of 17 subjects were examined for RT activity. Six
subjects (three SC, one SB and two SN) were utilised in our
earlier RT assays of crude pellet material. Despite the use of
both rA/dT and rC/dG primer/template systems no 'test'
sample yielded significant incorporation above background.
However, an experiment which involved addition of MMTV
to 'test' crude pellets revealed an inhibition of MMTV activ-
ity. This was attributed to the concentration of non-specific
inhibitors from the culture supernatant in the crude pellets.
Therefore culture supernatants collected from mononuclear
cell cultures of the remaining subjects were submitted to a
rA/dT based RT assay following 'virus' purification on su-
crose step gradients and concentration of harvested virus.
Conditions for this purification were established using
MMTV. The remaining subjects totalled 11 (three SC, three
Table II Analysis of the effect of AZA treatmenta
CTCM s.e. ofthe
CTCM + AZA n difference
Total cellfusions
SN mean: log scale 2.316 2.290 13 0.070
Mean: natural scale 202 190
SB mean: log scale 2.443 2.442 5 0.112
Mean: natural scale 272 272
SC mean: log scale 2.718 2.657 7 0.095
Mean: natural scale 517 449
Numbers oflarge cells
SN mean: log scale 1.307 1.257 13 0.122
Mean: natural scale 19 17
SB mean: log scale 1.361 1.389 5 0.197
Mean: natural scale 22 24
SC mean: log scale 1.916 1.756 7 0.166
Mean: natural scale 81 56
aOnly subjects which provided data in both CTCM and CTCM
supplemented with AZA were included in these analyses.
SB and five SN) and once again no test sample reproducibly
showed significant incorporation above background.
A known quantity of MMTV was run as a positive control
throughout virus purification procedures and in all RT
assays. Data indicate a 50% yield of virus from the sucrose
step gradient. Approximately 50% ofthis harvested virus was
recovered in the final concentrated viral pellet. Calculations
based on the RT activity of a known amount of our MMTV
positive control together with the sensitivity of its detection
in our RT assays indicate that if a human mammary tumour
virus was present in our SC cell cultures it must have been at
least a 100-fold less active or lower in concentration than the
MMTV positive control virus.
Electron microscopy
Transmission electron microscopy (TEM) was performed on
adherent mononuclear and multinucleate cell preparations
from two breast cancer patients following 10 or 21 days of in
vitro culture. TEM of thin sections failed to give conclusive
evidence of viral particles in the cytoplasm of the giant cells.
No structures consistent with MMTV or other retrovial par-
ticles (Figure 4, panel a) were observed. The vesicular struc-
tures which were seen resembled the coated vesicles normally
present in macrophages and giant cells (Figure 4, panels b
and c).
Discussion
This study, which was initially aimed toward purification and
molecular cloning of the described human mammary tumour
virus, resulted in an evaluation of MNGC formation and RT
activity in cultured blood monocytes and has provided data
which differ fundamentally from that previously reported
(Al-Sumidaie et al., 1988; Al-Sumidaie, 1986; Al-Sumidaie et
al., 1986). We found no clear cut difference in MNGC for-
mation between breast cancer and normal subjects. In con-
trast we observed significant numbers of MNGCs in virually
all cultures from the three groups and many cultures con-
tained far more MNGCs (per 105 adherent monocytes) than
previously reported. We found no significant difference in the
density per unit area of glass-adherent monolayers between
the SC, SB and SN groups. Any significant difference
between the groups in their rate of formation of MNGCs is
marginal. Direct t-tests between SC and SN groups were
significant at the 5% level, after adjustment for density, but
overall F-tests and non-parametric tests were not. The
observed trend of increasing fusions and large cells from the
normal group through the benign to the cancerous group is
suggestive, but the conclusions from this data set remain
equivocal because of the large subject to subject variation.
Possibly the greater MNGC formation by SC versus SN
monocytes was associated with lymphokine production by T
lymphocytes present in the monocyte enriched mononuclear
cell preparations studied (Weinberg et al., 1984; McInnes and
Rennick, 1988; Hassan et al., 1989).
Cells with two and three nuclei formed a substantial com-
ponent of the multinucleate cell population in our day 10
cultures and therefore were included in the calculation of
total cell fusions. These cells were either not observed or not
included in a previous study (Al-Sumidaie et al., 1986) in
which MNGCs were defined as having four or more nuclei.
However, analysis of our 'large cell' data with omission of
2 n and 3 n cell data did not increase the level of significance
between the SC and SN groups.
We used tissue culture slides for cultivation of monocyte
enriched cell preparations in preference to the under-agarose
cultivation technique described by Al-Sumidaie et al. (1984,
1986). Our culture system facilitated development of the
three morphological types of MNGCs (Al-Sumidaie, 1986;
Chambers & Spector, 1982) and was amenable for use in
both morphological and RT analysis. In addition, methods
previously described for generation of monocyte culture
supernatants for RT analysis clearly did not involve use ofTHE PUTATIVE HUMAN MAMMARY TUMOUR RETROVIRUS 539
Figure 4 Transmission electron micrographs of: a, Mouse mam-
mary tumour virus particles (arrowed) observed in spontaneous
mammary tumours. Bar = 100 nm. b, Segment of human
peripheral blood monocyte derived giant cell cytoplasm showing
structures resembling coated vesicles (arrowed). Bar = 1,000 nm.
c, Enlargement of an area in b, showing coated vesicles
(arrowed). Bar = 100 nm.
the under-agarose technique (Al-Sumidaie et al., 1988). Our
MNGCs showed active nuclei and some cultures contained
very large cells with up to 35 nuclei which resembled the
HIV-infected monocytes described by Collman et al. (1989).
However, the proportion of subjects showing these cells did
not differ significantly between the SC and SN groups, clearly
illustrating the need for caution against over-interpretation of
these qualitative observations. In an attempt to highlight the
differences in multinucleate cell formation between the
groups we examined the size distribution of MNGCs. In
addition we examined the effect of AZA treatment on total
fusions, numbers of large cells and on the size distribution of
MNGCs to see if the magnitude of any such effects differed
between the subject groups. In all of these analyses there was
no significant difference between the three groups. The lack
of any significant effect of AZA treatment on MNGC forma-
tion and thus on induction of the 'putative' latent human
mammary tumour retrovirus was consistent with our inability
to detect reverse transcriptase activity in the supernatant of
MNGC cultures. Taken together, the various analyses of our
MNGC data are self-supportive and are consistent with
literature reports of MNGC formation as a phenomenon
occurring in all in vitro cultured human monocytes. Zucker-
man et al. (1979) observed large multinucleated cells with
prominent nucleoli in day 6 cultures of normal human
monocytes. They report an increase in numbers of MNGC's
with time in their cultures which eventually contained giant
cells having more than 20 nuclei.
Our inability to detect significant reverse transcriptase
activity in supernatants of cells cultured from breast cancer
patients was inconsistent with a previous report (Al-Sumidaie
et al., 1988). The validity of our negative RT data for 'test'
subject supernatants was supported by the detection of high
levels of activity in the MMTV positive control utilised in all
assays. However, the RT assay we used would have been
limited to detecting greater than 105 particles/ml of culture
medium. Assay of 'virus' harvested from cultures containing
many more monocytes, may have been positive. Nevertheless
we have failed to detect RT activity in both crude pellets and
sucrose gradient purified material in contrast to the earlier
study (Al-Sumidaie et al., 1988) in which RT assays on crude
'viral' pellets generated from cultures containing equivalent
numbers of monocytes were positive. A review of relevant
literature revealed that the poly G/dC primer/template util-
ised by Al-Sumidaie et al. (1988) is not commonly used for
assay of RT and that optimal reaction conditions vary con-
siderably from one RT enzyme to another (Baltimore &
Smoler, 1971; Dion et al., 1974; Tomley et al., 1983; Dick-
son, 1973; Hoffman, 1985; Varmus & Swarnstrom, 1982).
For example, we found the activity of recombinant HIV-RT
detected in a poly A/dT system to be reduced by 97% when
similarly assayed in the poly G/dC system (data not shown).
Following our initial findings ofnegative RT activity in 'test'
pellets assayed in the poly G/dC system the majority of our
experiments utilised reaction conditions which represented a
compromise of those optimal for MMTV (Dickson, 1973)
and those preferred by HIV and other mammalian retro-
viruses (Hoffman, 1985; Varmus & Swarnstrom, 1982).
The RT data supported our preliminary E.M. observations
on sections of cultured monocytes and MNGCs in which no
particles resembling a retrovirus could be identified with
certainty. However, as only two breast cancer subjects were
studied in this way the E.M. data are inconclusive. Transmis-
sion electron micrographs reported to show viral particles in
MNGCs (Al-Sumidaie et al., 1988) have been questioned by
Kirk and Gardiner (1988). They state that the structures
described as viral particles did not show specific structural
features of retroviruses and were indistinguishable from
clathrin-coated vesicles normally associated with receptor
mediated endocytosis (Brown et al., 1983).
In summary, we have studied giant cell formation and
searched for RT activity in adherent peripheral blood mono-
nuclear cells from breast cancer, benign breast tumour and
normal subjects. Our findings contradict reports of a clear-
cut difference in MNGC formation between SN and SC
donors. In addition MNGC formation was not influenced by
AZA treatment and we were not able to detect RT activity in
supernatants of AZA treated SC monocyte cultures despite
diligent search. These data are salient to our conclusion that
evidence for a difference between the SC and SN groups in
MNGC formation is marginal and almost certainly is not
attributable to the presence of a retrovirus in SC cultures.
The overall conclusion from this study is that there is a lack
of compelling evidence for the association of a retrovirus
with blood monocytes of breast cancer patients.
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